TRG increased the activity of liver fatty acid synthase (FAS), liver carnitine palmitoyl transferase (CPT), and glucokinase (GLK), and decreased the serum and liver triglyceride (TG) levels, suggesting that it could suppress both TG accumulation and the progression of diabetes through the regulation of these enzymes’ activities [63]. This evidence concerns the gene GCK and diabetes mellitus.